Z-1798-2013 Class II Terminated
FDA device recall Z-1798-2013 was initiated by Becton Dickinson & Co. on Jun 6, 2013 and is designated Class II. Reason for recall: Microbiological identification media may exhibit reduced levels of Vancomycin. The recall status is terminated (terminated Sep 3, 2013). Affected quantity: 911 cartons.
Recall Details
- Product Type
- Devices
- Report Date
- Jul 31, 2013
- Initiation Date
- Jun 6, 2013
- Termination Date
- Sep 3, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 911 cartons
Product Description
BD BBL Vancomycin Screen Agar, carton of 10 plates, catalog # 222204, labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Vancomycin Screen Agar is used to test entercocci for resistance to vancomycin and to predict the synergistic activity of this antimicrobial with an aminoglycoside antimicrobial.
Reason for Recall
Microbiological identification media may exhibit reduced levels of Vancomycin.
Distribution Pattern
Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
Code Information
Lot 3081136 Exp June 18, 2013 Lot 3073114 Exp June 12, 2013
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1798-2013
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026